News
Voltalia SA: new power sales contracts in France
Voltalia SA: new power sales contracts in France
Showroomprive.com: INFORMATION REGARDING THE CONSEQUENCES OF THE COVID-19 EPIDEMIC
Showroomprive.com: INFORMATION REGARDING THE CONSEQUENCES OF THE COVID-19 EPIDEMIC
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
RUBIS: Disclosure of the total number of voting rights and of the number of shares on 03/31/2020
RUBIS: Disclosure of the total number of voting rights and of the number of shares on 03/31/2020
Voltalia SA: total number of shares and voting rights in the share capital as of February 29, 2020
Voltalia SA: total number of shares and voting rights in the share capital as of February 29, 2020
ALD appoints Tim Albertsen as CEO
ALD appoints Tim Albertsen as CEO
ALD: Impact of Covid-19
ALD: Impact of Covid-19
Voltalia SA: Availability of the 2019 Universal Registration Document
Voltalia SA: Availability of the 2019 Universal Registration Document
Kaufman & Broad SA: AMENDMENT OF THE MANDATE FOR THE SHARE BUYBACK PROGRAM
Kaufman & Broad SA: AMENDMENT OF THE MANDATE FOR THE SHARE BUYBACK PROGRAM
ALD and Mitsubishi UFJ Lease & Finance Company to launch joint venture operations in Malaysia
ALD and Mitsubishi UFJ Lease & Finance Company to launch joint venture operations in Malaysia
Voltalia SA: 2019 second half rebound, as expected - Long-term visibility and growth secured with over €5 billion of future revenues under contracts
Voltalia SA: 2019 second half rebound, as expected - Long-term visibility and growth secured with over €5 billion of future revenues under contracts
Pharnext Announces Identification of a Large Set of Frequently Prescribed Drugs to be Repurposed for Fighting COVID-19, Using its PleotherapyTM Platform
Pharnext Announces Identification of a Large Set of Frequently Prescribed Drugs to be Repurposed for Fighting COVID-19, Using its PleotherapyTM Platform
Kaufman & Broad SA: Invitation for the first quarter 2020 results
Kaufman & Broad SA: Invitation for the first quarter 2020 results
Kaufman & Broad SA: Q1 2020 RESULTS
Kaufman & Broad SA: Q1 2020 RESULTS
Voltalia SA: Voltalia signed a power sales contract and started construction of its new VSM 3 wind farm, at Serra Branca in Brazil /Serra Branca is the biggest wind-and-solar cluster worldwide
Voltalia SA: Voltalia signed a power sales contract and started construction of its new VSM 3 wind farm, at Serra Branca in Brazil /Serra Branca is the biggest wind-and-solar cluster worldwide
Kaufman & Borad SA: Invitation for the first quarter 2020 results
Kaufman & Borad SA: Invitation for the first quarter 2020 results
Pharnext Announces PXT3003 for the Treatment of Charcot-Marie-Tooth Disease Type 1A has Been Granted Promising Innovative Medicine (PIM) Designation by UK Medicines and Healthcare Products Regulatory Agency
Pharnext Announces PXT3003 for the Treatment of Charcot-Marie-Tooth Disease Type 1A has Been Granted Promising Innovative Medicine (PIM) Designation by UK Medicines and Healthcare Products Regulatory Agency
DGAP-News: Abivax veröffentlicht Finanzergebnisse für das Jahr 2019 und gibt Update zur Unternehmensentwicklung
DGAP-News: Abivax veröffentlicht Finanzergebnisse für das Jahr 2019 und gibt Update zur Unternehmensentwicklung
DGAP-News: Abivax 2019 Financial Results and Operations Update
DGAP-News: Abivax 2019 Financial Results and Operations Update
Showroomprive.com: Annual Results 2019 - Sharp impact of exceptional operations on stock (large clearance and depreciation)
Showroomprive.com: Annual Results 2019 - Sharp impact of exceptional operations on stock (large clearance and depreciation)
RUBIS : 2019 ANNUAL RESULTS
RUBIS : 2019 ANNUAL RESULTS
DGAP-News: Abivax Finanzkalender 2020
DGAP-News: Abivax Finanzkalender 2020
DGAP-News: Abivax 2020 Financial Communication Calendar
DGAP-News: Abivax 2020 Financial Communication Calendar
Kaufman & Broad SA: AMENDMENT OF THE MANDATE FOR THE SHARE BUYBACK PROGRAM
Kaufman & Broad SA: AMENDMENT OF THE MANDATE FOR THE SHARE BUYBACK PROGRAM
Pharnext raises € 7.7 million in a private placement
Pharnext raises € 7.7 million in a private placement